Journal article · 2026 · Open access
Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery
Pharmacological Reviews, 100165 · Published 1 October 2026 · DOI 10.1016/j.pharmr.2026.100165
In brief
“Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery” is a 2026 journal article by Golap Babu and 3 co-authors, published in Pharmacological Reviews. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmacological Reviews.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 1.18
- References
- 196
- Authors
- 4
Abstract
Melanotransferrin (MTf; also known as MFI2, MELTF, CD228, or tumor antigen p97) is an intriguing glycosylphosphatidylinositol (GPI)-anchored member of the transferrin superfamily whose cell-surface localization, internalization, molecular heterogeneity, and context-dependent signaling create several pharmacological opportunities. This review evaluates three distinct strategies. First, membrane MTf is a tumor-associated target for ricin immunotoxins, auristatin antibody-drug conjugates such as SGN-CD228A, SNAP-tagged conjugates, photoimmunotherapy, and immune-stimulatory agents. Their activity depends on MTf abundance and also antigen heterogeneity, internalization, intracellular routing, payload sensitivity, soluble or vesicular antigen sinks, and normal-tissue exposure. Second, MTf-associated tumor biology may be targeted through Wingless-related integration site (WNT)/β-catenin/p21-activated kinase 4 (PAK4) signaling and/or induction of the metastasis suppressor, N-myc downstream regulated gene-1 (NDRG1). In fact, a Yin-Yang relationship exists between NDRG1 and MTf levels in multiple tumor cell types and patient tumor samples. Third, soluble MTf and MTf-derived transport vectors provide a mechanistically separate opportunity for therapeutic delivery across the blood-brain barrier. Full-length soluble MTf has been conjugated to small molecules and antibodies, although rapid hepatic clearance and uncertainty regarding intact cargo delivery remain limitations. Particularly notable is MTfp, a conserved 12-amino-acid MTf-derived peptide that delivered biologically active cargo in preclinical models. The sequence-reversal controls of MTfp support sequence-dependent transport, although its receptor, human pharmacokinetics, and cargo generalizability remain undefined. Soluble MTf has also been investigated as a circulating biomarker, although its clinical validation remains insufficient. In the future, distinguishing membrane-bound, soluble, vesicle-associated, and peptide forms of MTf is essential for defining target engagement, exposure, response, and safety.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Babu, G., Suri, P., Godugu, D., & Richardson, D. R. (2026). Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery. Pharmacological Reviews, 100165. https://doi.org/10.1016/j.pharmr.2026.100165
MLA 9
Babu, Golap, et al. “Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery.” Pharmacological Reviews, 2026, p. 100165. https://doi.org/10.1016/j.pharmr.2026.100165.
Chicago
Babu, Golap, Parul Suri, Deepika Godugu, and Des R. Richardson. 2026. “Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery.” Pharmacological Reviews: 100165. https://doi.org/10.1016/j.pharmr.2026.100165.
Harvard
Babu, G. et al. (2026) ‘Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery’, Pharmacological Reviews, p. 100165. doi:10.1016/j.pharmr.2026.100165.
IEEE
G. Babu, P. Suri, D. Godugu, and D. R. Richardson, “Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery,” Pharmacological Reviews, p. 100165, 2026, doi: 10.1016/j.pharmr.2026.100165.
BibTeX
@article{babu2026melanotransferrin,
title = {{Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery}},
author = {Babu, Golap and Suri, Parul and Godugu, Deepika and Richardson, Des R.},
journal = {Pharmacological Reviews},
year = {2026},
pages = {100165},
doi = {10.1016/j.pharmr.2026.100165},
url = {https://doi.org/10.1016/j.pharmr.2026.100165}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- melanotransferrin
- tumor-associated antigens
- antibody-drug conjugates
- photoimmunotherapy
- antigen uptake
- Wnt/β-catenin signaling
- PAK4
- NDRG1
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Babu, G., Suri, P., Godugu, D., & Richardson, D. R. (2026). Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery. Pharmacological Reviews, 100165. https://doi.org/10.1016/j.pharmr.2026.100165
How many times has this paper been cited?
1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Pharmacological Reviews: sign in and open the full text from this page.
Who wrote this paper?
Golap Babu, Parul Suri, Deepika Godugu, Des R. Richardson.
What is the DOI of this paper?
10.1016/j.pharmr.2026.100165, permanently at https://doi.org/10.1016/j.pharmr.2026.100165. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.